¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÚÉøÍ¸Óë´úл²¡Ñ§¿Æ³ÂÑàÃú½ÌÊÚ¡¢¡¢ºÎѧÃô¿ÎÌâ×éºÍÃÀ¹úHarold HammÌÇÄò²¡Ñо¿ÖÐÐÄÂí½¨Ð½ÌÊÚÔÚ¹ú¼Ê×ÅÃûÆÚ¿¯Signal Transduction and Targeted Therapy£¨IF 13.49£©½ÒÏþÁËÌâΪ¡°A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-¦Â/Smad signaling ¡±µÄÑо¿ÂÛÎÄ¡£ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÚÉøÍ¸Óë´úл²¡Ñ§¿ÆºÎѧÃô²©Ê¿ÊǸÃÂÛÎĵĵÚÒ»×÷Õߣ¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÈýÒ½ÔºÄÚÉøÍ¸Óë´úл²¡Ñ§¿ÆÊǵÚÒ»×÷Õßµ¥Î»¡£
ÉöÔàÏËά»¯ÊÇÉö¹¦Ð§ËðÉ˵ÄÖ÷Òª²¡ÀíÌØÕ÷£¬£¬£¬ÉöÔàÏËά»¯µÄÀú³ÌÈôÊDz»¿É±»×è¶Ï£¬£¬£¬¾Í»áµ¼ÖÂÉö¹¦Ð§Öð½¥Ëðʧ£¬£¬£¬½ø¶øµ¼ÖÂÄò¶¾Ö¢£¬£¬£¬ÌÇÄò²¡Éö²¡¼°¹£×èÐÔÉö²¡ÊÇÓÕ·¢ÉöÔàÏËά»¯µÄÖ÷Òª²¡ÒòÖ®Ò»£¬£¬£¬Ñо¿ÉöÔàÏËά»¯µÄ·¢²¡»úÖÆ¡¢¡¢×èÖ¹ÉöÔàÏËά»¯±¬·¢¿ªÕ¹£¬£¬£¬¶ÔÖÎÁÆÉöÔ༲²¡¾ßÓкÜÊÇÖ÷ÒªµÄÁÙ´²ÒâÒå¡£
Ñо¿·¢Ã÷£¬£¬£¬µÍÃܶÈÖ¬ÂѰ×ÊÜÌåÏà¹ØÂѰ×5£¨LRP5£©ÓëÉöÔàÏËά»¯Ç×½üÏà¹Ø£¬£¬£¬ÔÚÌÇÄò²¡Éö²¡ºÍ¹£×èÐÔÉö²¡Ä£×ÓÖУ¬£¬£¬Ëæ×ż²²¡µÄÏ£ÍûLRP5µÄ±í´ïÁ¿ÏÔ×ÅÉý¸ß£¬£¬£¬²¢ÇÒÖ÷ÒªÂþÑÜÔÚÉöС¹Ü¡£½ÓÄÉLRP5»ùÒòÇóýÊó½øÒ»²½·¢Ã÷£¬£¬£¬Ïµ÷LRP5ȷʵÄܼõÇáÉöÔàÏËά»¯£»£»£»Í¨¹ýÓ«¹âȾɫ£¬£¬£¬Co-IPÓëϸ°û×é·ÖÊèÉ¢µÈÊÖÒÕ£¬£¬£¬½øÒ»²½Ö¤ÊµÎúLRP5Ö±½ÓÓëTGF-¦ÂÊÜÌåÁ¬Ïµ£¬£¬£¬¸Ä±äTGF-¦ÂÊÜÌåÔÚϸ°ûĤÉϵijÊÏÖºÍÄÚÍÌ£¬£¬£¬´Ó¶øÓ°ÏìÁËTGF-¦Â/Smad2/3ÐźÅͨ·µÄ¼¤»î£¬£¬£¬¼ÓÈëÉöÔàÏËά»¯µÄÏ£Íû¡£´ËÑо¿Ê×´ÎÔÚÉöÏËά»¯ÁìÓòÄÚÕ¹ÏÖÁËLRP5µÄй¦Ð§£¬£¬£¬LRP5×÷ΪTGF-b/Smad2/3ÐźÅͨ·µÄ¹²ÊÜÌåÀ´µ÷ÀíÉöÏËά»¯£¬£¬£¬ÎªÉöÔ༲²¡µÄÖÎÁÆÌṩае㡣º£ºóÐø¿ÎÌâ×齫ÉîÈëÑо¿Æä¸ÉÔ¤ÒòËØ£¬£¬£¬ÖÂÁ¦ÓÚÁÙ´²Ó¦ÓõÄת»¯¡£
ÂÛÎÄÁ´½Ó£º£ºhttps://pubmed.ncbi.nlm.nih.gov/32345960/